Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals, Inc. develops and markets generic and proprietary injectable, inhalation, and intranasal products in the U.S., China, and France, offering emergency epinephrine inhalers, anticoagulants, diagnostic agents, and recombinant insulin APIs.

Headquarters: United States (USA)

Amphastar Pharmaceuticals Inc. Logo
Company Profile
  • Employees: 2,028
  • HQ: Rancho Cucamonga
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
AMPH Amphastar Pharmaceuticals Inc.
Cap: 1.3B | P/E: 12.2
EQUITY NMS USD US03209R1032 Active
📈
Home Login